Successful use of recombinant FVIIa (Novoseven) in the management of pulmonary haemorrhage secondary to Aspergillus infection in a patient with leukaemia and acquired FVII deficiency.
White
B
B
Martin
M
M
Kelleher
S
S
Browne
P
P
McCann
S R
SR
Smith
O P
OP
D000208:Acute Disease; D001228:Aspergillosis / Q000150:complications*; D005168:Factor VII Deficiency / Q000209:etiology; D015942:Factor VIIa / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications; D008171:Lung Diseases / Q000188:drug therapy*; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D015942:Factor VIIa